Recurrent Pregnancy Loss: What the Pattern Reveals Beyond the Standard Workup
If you have had more than one miscarriage, you are carrying something most people around you cannot fully see.
The grief of pregnancy loss is real and it does not follow a timeline. Neither does the pressure to keep going, to stay positive, to not fall apart while you are still trying. If you have felt any of that, you are not alone and you are not doing it wrong.
What we want to do in this article is give you something useful to work with. Not to replace the grief or rush past it, but because one of the most disorienting parts of recurrent loss is not knowing whether anything can actually change. Whether the next pregnancy will hold. Whether there is something that has been missed.
In most of the cases we review at Fab Fertile, there is.
Couples come to us after the standard path has run out of answers. Testing came back normal. They were told to keep trying. Some were told to wait until a third loss before anyone would look deeper. And when we actually evaluate the full picture the immune environment, the clotting markers, the gut, the thyroid, the adrenal rhythm, the vaginal microbiome, the sperm we find things that were never investigated.
This article is about what those things are and why the standard workup is not built to find them.
Download the Embryo Audit Checklist to start reviewing what may have been missed in your case.
Download the Embryo Audit Checklist
What is recurrent pregnancy loss?
Recurrent pregnancy loss (RPL) is defined as two or more consecutive pregnancy losses before 20 weeks of gestation. It affects approximately 1 to 2 percent of couples trying to conceive. A cause is identified in fewer than half of cases through standard testing. At Fab Fertile, when a cause has not been found, that does not mean one does not exist. It means the right questions have not yet been asked.
Why does recurrent pregnancy loss happen?
In most cases recurrent pregnancy loss is not caused by a single factor. The pattern we consistently see at Fab Fertile involves multiple overlapping systems: immune dysregulation including elevated natural killer cell activity and antinuclear antibodies; inflammatory and clotting burden measured through homocysteine and high-sensitivity C-reactive protein (hsCRP); hormonal instability across thyroid, progesterone, and adrenal function; gut dysbiosis and vaginal microbiome imbalance driving immune activation; and sperm DNA fragmentation in the male partner. Standard RPL workups evaluate some of these, usually after a third loss, but rarely all of them and rarely in the context of how they interact. A functional evaluation looks at the full pattern before the next pregnancy, not after another loss.
Why Implantation Occurs But Stability Fails
Most people think of miscarriage as something that happens before pregnancy is established. But recurrent early loss particularly in the first trimester tells a different biological story. Implantation is occurring. The embryo is attaching. What is failing is the environment that was supposed to sustain it.
Understanding that distinction changes everything about where you look for answers.
When an embryo implants, it does not just attach to the uterine lining and wait. It actively invades the endometrium, triggers a highly coordinated immune response, and begins remodeling the spiral arteries that will eventually supply the placenta. That process requires immune tolerance the uterine environment has to recognize the embryo as something to protect, not something to attack. It requires adequate progesterone to maintain the luteal phase and support endometrial receptivity. It requires healthy blood flow and clotting regulation so the developing placenta can establish circulation without interruption. And it requires that the embryo itself has the chromosomal and mitochondrial integrity to sustain that level of biological demand.
When any of those conditions are compromised, the pregnancy may establish and then fail. Not because implantation did not work. Because the environment could not hold it.
This is the biological basis for why recurrent loss is a systems question, not a single-factor diagnosis. And it is why the standard workup which focuses primarily on uterine anatomy and clotting disorders, and only after multiple losses captures such a narrow slice of what is actually driving the pattern.
The systems we look at in a functional evaluation map directly onto the biology of early pregnancy maintenance: immune regulation, inflammatory and clotting burden, hormonal environment, gut and microbiome health, and the paternal contribution to embryo quality. Each of those is a door into why stability fails. None of them is optional when the pregnancy keeps ending in the same window.
The Conventional Standard of Care and What It Misses
The conventional approach to recurrent pregnancy loss is not wrong. It is just incomplete. And the gap between what gets investigated and what is actually driving the pattern is where most couples spend years without answers.
Here is what the standard workup typically includes.
After two or three losses and in many guidelines it is still three a Reproductive Endocrinology and Infertility (REI) specialist will order a panel that covers uterine anatomy, usually via hysteroscopy or saline sonogram; parental karyotyping to rule out chromosomal translocation; antiphospholipid antibody syndrome testing including lupus anticoagulant and anticardiolipin antibodies; and sometimes thrombophilia screening for factor V Leiden and prothrombin gene mutation. If thyroid-stimulating hormone is flagged as abnormal, thyroid function may be evaluated. Progesterone may be tested in the luteal phase or early pregnancy.
That panel identifies a cause in roughly 50 percent of cases. In the other half, the workup comes back normal and couples are told their loss is unexplained.
What the standard workup does not routinely investigate is a longer list.
Natural killer (NK) cells are not part of standard RPL evaluation, despite published research connecting elevated NK activity to implantation failure and early pregnancy loss. Antinuclear antibodies (ANA) are rarely ordered unless there is an existing autoimmune diagnosis, yet ANA positivity has been documented in women with otherwise unexplained RPL. Thyroid peroxidase antibodies are not routinely checked even though thyroid autoimmunity is independently associated with miscarriage risk even when thyroid-stimulating hormone is within the normal range.
Homocysteine is almost never measured in a standard RPL workup despite its role in clotting, methylation, and placental development. A pattern we consistently see: homocysteine is elevated, B12 and folate status are suboptimal, and MTHFR variants are present none of which were evaluated because the standard thrombophilia panel does not include them.
Gut health is not considered part of recurrent pregnancy loss evaluation in conventional medicine. Yet gut dysbiosis directly influences immune regulation, estrogen metabolism, and the inflammatory environment of the uterus. Vaginal microbiome imbalance, particularly low Lactobacillus crispatus dominance, has been associated with implantation failure and early loss and is almost never tested.
Adrenal function and cortisol rhythm are not part of the standard picture. Sperm DNA fragmentation is not ordered unless semen analysis is abnormal, which means couples where the male partner has normal count, motility, and morphology but significant DNA damage go entirely uninvestigated on that front.
And the timing problem compounds all of it. Waiting for a third loss before beginning a thorough investigation means couples go through another pregnancy, another loss, and another round of grief before anyone looks deeper. That is the standard of care. It is not a reflection of what the biology actually requires.
At Fab Fertile, we do not wait. We look at the full pattern after the first loss if the clinical picture warrants it, and certainly after two. Because the goal is not to confirm a diagnosis after enough losses have accumulated. The goal is to understand what the body is telling us before the next pregnancy begins.
Check out our episode on how to be your own advocate with pregnancy loss for more on navigating this process and asking the right questions at your next appointment.
One Couple's Experience: Gayathri and Josh
Gayathri and Josh came to Fab Fertile after two years of trying to conceive and multiple early miscarriages.
They were not starting from zero. They had already changed their diet. They had made significant lifestyle adjustments. They had done what most people do when the standard answers run out they kept researching, kept trying, kept showing up. And nothing was holding.
What they did not yet have was a full picture of what was actually driving the losses. Not a guess. Not a protocol built on general recommendations. A specific, tested, personalized picture of what their bodies were telling them.
When we worked through that picture together, seven patterns emerged that had never been fully evaluated or addressed: gut infections, food sensitivities, adrenal insufficiency, thyroid imbalance, immune imbalance, circadian rhythm disruption, and mental and emotional stress load. Not as a checklist. As an interconnected set of systems that were each contributing to an environment that could not sustain a pregnancy.
That is the work. Not one change. Not one supplement. The full picture, addressed in a way that is specific to what the testing actually shows.
Gayathri and Josh were pregnant naturally five months after joining the Fab Fertile Method. They now have a beautiful baby girl.
Their story is not unusual in our community. It is what becomes possible when the investigation matches the complexity of what is actually happening.
Watch Gayathri and Josh share their story: Successful Natural Pregnancy After Recurrent Pregnancy Loss
A Note on the Emotional Weight of This Journey
Before we get into the biology, we want to acknowledge something.
Recurrent pregnancy loss is not just a clinical problem. It is one of the most isolating experiences a couple can go through. The grief is real. The shame that often comes with it the questioning of what you did wrong, whether your body is broken, whether you deserve this is real too, even when it is not warranted.
Women are often not encouraged to talk about pregnancy loss. Partners carry their own grief while trying to hold everything together. And the pressure to stay positive while still trying adds a layer of emotional complexity that the clinical conversation almost never makes space for.
If you are in that place right now, you do not have to move through this alone and you do not have to choose between honoring the grief and continuing to look for answers. Both are possible at the same time.
Listen to our episode on
how to honor your miscarriage as you prepare to try again
and our episode on
navigating the mental and emotional side of pregnancy loss.
The biology matters. So does everything you are carrying alongside it.
Five Patterns We Consistently See in Recurrent Pregnancy Loss
These are not the only factors that contribute to recurrent loss. But they are the ones that come up most consistently in our case reviews and the ones that are most reliably missed in a standard workup. Each pattern is specific to RPL though you will see natural overlap with other articles in this series, because the underlying systems are the same ones that drive poor egg quality, embryo arrest, and repeated IVF failure.
Pattern 1: Immune Activation and Natural Killer Cell Dysregulation
The immune system plays a central role in early pregnancy. For implantation to succeed and a pregnancy to hold, the uterine immune environment has to shift into a state of tolerance recognizing the embryo as something to protect rather than eliminate. When that shift does not happen correctly, the immune system can attack the developing pregnancy even when everything else looks normal.
Natural killer (NK) cells are a key part of this picture. Uterine NK cells in appropriate concentrations and activity levels actually support implantation by helping remodel the spiral arteries that supply the placenta. But when NK cell activity is elevated or dysregulated, that same mechanism can become destructive. Research has documented associations between elevated peripheral NK cell activity and recurrent pregnancy loss, and between uterine NK cell concentration and implantation failure yet NK cell testing is not part of standard RPL evaluation and remains controversial in conventional reproductive medicine despite the evidence base.
Antinuclear antibodies are another pattern we investigate. ANA positivity has been documented in women with otherwise unexplained RPL, and the immune activation it reflects can create a hostile environment for early pregnancy even when the ANA titre is not high enough to trigger a formal autoimmune diagnosis. The same applies to antiphospholipid antibodies beyond the standard lupus anticoagulant and anticardiolipin panel a broader immune picture is often warranted when losses are unexplained.
Thyroid autoimmunity sits inside this pattern too. Thyroid peroxidase antibody positivity is independently associated with increased miscarriage risk even when TSH is within the standard normal range. A 2025 meta-analysis confirmed that thyroid autoimmunity is associated with higher miscarriage rates in both natural and assisted conception cycles. The functional target for TSH at Fab Fertile is 0.5 to 2.0 mIU/mL tighter than the standard reference range because subclinical thyroid dysfunction that falls within conventional normal limits can still be contributing to immune dysregulation and pregnancy instability.
The pattern we often see: a woman with recurrent unexplained loss, normal uterine anatomy, normal standard clotting panel, and a personal or family history of autoimmune conditions. Thyroid antibodies elevated but TSH technically normal. ANA positive but below diagnostic threshold. NK activity never tested. Each marker individually dismissed. Collectively, a clear immune picture that was never assembled.
For more on how immune signaling intersects with fertility outcomes, see our article on Inflammation, Immune Signaling, and Fertility Outcomes. For the connection between thyroid autoimmunity and implantation failure specifically, our episode on autoimmune roadblocks to IVF and how ANA affects fertility goes deeper.
Pattern 2: Clotting and Inflammatory Burden
The standard thrombophilia panel factor V Leiden, prothrombin gene mutation, protein C and S deficiencies, antiphospholipid antibodies catches a real subset of clotting-related loss. But it is a narrow panel, and the clotting picture in recurrent pregnancy loss is broader than what it measures.
Homocysteine is one of the most consistently overlooked markers in RPL. Elevated homocysteine impairs placental blood flow, increases clotting risk, and reflects methylation dysfunction that can compromise both egg quality and early embryo development. The functional target at Fab Fertile is 6.0 to 7.2 micromoles per litre. A pattern we see regularly: homocysteine elevated, B12 low or falsely normal due to poor absorption, folate as folic acid rather than methylfolate in the prenatal, MTHFR variants present. None of it connected. None of it investigated because homocysteine is not on the standard RPL panel.
High-sensitivity C-reactive protein (hsCRP) reflects systemic inflammatory burden and is another marker rarely ordered in RPL evaluation. The functional target is below 1 mg/L. Chronic low-grade inflammation from gut dysbiosis, food sensitivities, environmental toxin load, or unresolved infections creates a pro-inflammatory uterine environment that disrupts the immune tolerance window required for pregnancy maintenance. When hsCRP is elevated and the source has not been identified, the inflammatory trigger is still present in the next pregnancy.
The clotting and inflammatory patterns interact. Elevated homocysteine drives inflammation. Inflammation amplifies clotting risk. Gut dysbiosis amplifies both. Addressing one without the others leaves the picture incomplete.
For more on the clotting and inflammation connection in pregnancy loss, listen to our episode on the clotting connection -- hidden causes of implantation failure and miscarriage. For the broader inflammatory picture, see our episode on beyond hormones -- why inflammation may be driving poor egg quality and miscarriage.
Pattern 3: Hormonal Instability Progesterone, Thyroid, and Adrenal Function
Progesterone is the hormone most commonly associated with early pregnancy loss, and it is the one most likely to be addressed in a conventional workup. But the way it is typically addressed supplementation after a positive pregnancy test, often with synthetic progesterone does not ask the more important question. Why is progesterone low to begin with?
Progesterone insufficiency in early pregnancy can reflect poor corpus luteum function, which is downstream of egg quality and ovulation. It can reflect adrenal dysfunction, because the adrenal glands are a secondary source of progesterone and chronic stress load depletes that reserve. It can reflect thyroid dysfunction, because thyroid hormone is required for adequate progesterone production and luteal phase support. And it can reflect nutrient deficiencies magnesium, zinc, and vitamin B6 are all involved in progesterone synthesis and are commonly low in women with recurrent loss.
Supplementing progesterone without investigating those upstream drivers means the next pregnancy starts with the same underlying conditions. When progesterone is low, we want to know why not just replace it.
Adrenal function is a particularly underevaluated piece of this pattern. Chronic stress activates the hypothalamic-pituitary-adrenal axis, elevates cortisol, and suppresses the reproductive signaling pathway. The Dried Urine Test for Comprehensive Hormones (DUTCH) gives us a full cortisol rhythm picture not just a single blood draw and consistently reveals patterns that a standard cortisol test misses entirely. Elevated cortisol, flattened cortisol curve, and elevated reverse T3 are all stress-state adaptations that de-prioritize pregnancy maintenance. The body under chronic stress is not choosing to lose pregnancies. It is responding to a load that has never been fully evaluated.
For more on how the nervous system and cortisol rhythm affect fertility outcomes, see our article on Nervous System Load and Fertility Outcomes. For the progesterone and thyroid connection specifically, our episode on progesterone, low AMH, miscarriage -- what you are missing covers the full picture. And if stress load is something you are carrying right now, our episode on whether quitting your job could help you get pregnant faster addresses the cortisol and reproductive load question directly.
Pattern 4: Gut Dysbiosis, Vaginal Microbiome, and Immune Crosstalk
The gut is not a fertility organ in the conventional sense. But in a functional evaluation, it is central to almost every system that determines whether a pregnancy holds.
Gut dysbiosis bacterial imbalance, infections, parasites, fungal overgrowth drives systemic inflammation, impairs nutrient absorption, and disrupts the estrobolome, the subset of gut bacteria responsible for metabolizing and clearing estrogens. When the estrobolome is compromised, estrogen recirculates rather than clears, amplifying autoimmune activity and altering the hormonal environment of early pregnancy. When gut infections are present, the immune system is in a state of chronic activation that directly affects uterine immune tolerance.
Food sensitivities are part of this pattern and are almost never investigated in a conventional RPL workup. Unlike immediate allergic reactions, food sensitivity reactions are delayed the inflammation they trigger accumulates over hours or days and drives immune activation that is invisible on standard testing. We have worked with couples where removing reactive foods as part of an elimination diet, followed by targeted food sensitivity testing, was one of the clearest turning points in a pattern of recurrent loss. The body mounts an immune response to foods it cannot tolerate. That immune activation does not stop at the gut wall.
The vaginal microbiome is a separate but related system. Lactobacillus crispatus dominance in the vaginal environment is associated with successful implantation and reduced miscarriage risk. Dysbiosis in the vaginal microbiome particularly the presence of anaerobic bacteria has been associated with implantation failure and early pregnancy loss. Vaginal microbiome testing is not part of standard RPL evaluation and is rarely discussed. When we see recurrent loss with no identified cause, it is one of the first things we look at.
The gut and vaginal microbiome are connected. Supporting gut health benefits vaginal flora. Addressing infections in one environment without the other leaves the picture incomplete.
For more on the gut and fertility connection, listen to our episode on why your gut microbiome matters for low AMH and high FSH. For the impact of gluten and immune activation on pregnancy loss specifically, our article on the impact of gluten on embryo implantation, pregnancy loss, NK cells, and AMH and FSH levels is directly relevant. And for the functional testing approach to gut health in recurrent loss, our episode on 8 functional medicine steps to take for miscarriage walks through the protocol in detail.
Pattern 5: Paternal Contribution Sperm DNA and Oxidative Load
Recurrent pregnancy loss is almost always framed as a female issue. The male partner gets a semen analysis, it comes back normal, and that is considered sufficient. It is not.
Standard semen analysis measures count, motility, and morphology. It does not measure sperm DNA integrity. And sperm DNA fragmentation damage to the genetic material inside the sperm is directly associated with early pregnancy loss, poor embryo development, and failed IVF cycles even when all standard semen parameters are normal.
A 2025 study of 870 ICSI cycles found that each 1 percent increase in sperm DNA fragmentation reduced the odds of achieving top-quality blastocysts on Day 5 by 2.5 percent. A 2019 meta-analysis in Human Reproduction Update found that high sperm DNA fragmentation is significantly associated with recurrent pregnancy loss, with an odds ratio of 2.16 compared to fertile controls independent of standard semen parameters. In the context of recurrent loss, where the embryo is implanting but not surviving, the paternal DNA contribution to embryo stability is not a secondary consideration. It is a primary one.
The drivers of sperm DNA fragmentation are the same systems we investigate on the female side: oxidative stress, gut infections, inflammatory load, nutrient deficiencies, environmental toxin exposure. A man with a normal semen analysis can have significant DNA fragmentation driven by any of those factors. And because it is never tested in a standard workup, it goes unaddressed cycle after cycle.
Gayathri and Josh's story illustrates this directly. The Fab Fertile Method evaluates both partners. Because recurrent loss is a couple's issue, not a female issue.
For more on the male contribution to embryo outcomes and recurrent loss, see our article on Male Factor Fertility: The Overlooked Variable in Embryo Outcomes and our episode on how to address men's reproductive health.
Not Sure Where to Start?
Most couples who come to us for a Functional Fertility Second Opinion have already done the standard workup. The testing came back normal. Or a cause was identified and addressed and the losses continued anyway.
A normal result on a standard panel is not the same as a full picture. It means the tests that were ordered did not find what they were looking for. It does not mean there is nothing to find.
If you have had more than one miscarriage and are still looking for answers, the next step is not another cycle with the same inputs. It is a review of what has not yet been evaluated.
That is what a Functional Fertility Second Opinion does. We look at the full pattern immune, inflammatory, hormonal, gut, microbiome, and sperm and tell you specifically what has been missed and what is worth addressing before the next pregnancy.
Recurrent Pregnancy Loss: When Implantation Occurs but Stability Fails
This is huge for your immune, inflammation, and system positioning.
Why Most Plans Miss the Mark
You were told a cause could not be found, so the recommendation was to keep trying.
But unexplained recurrent pregnancy loss is not a biological verdict. It is a data gap. The testing that was ordered was not designed to find immune dysregulation, gut-driven inflammation, vaginal microbiome imbalance, methylation dysfunction, or sperm DNA damage. When those systems are not evaluated, they cannot be found. That is not the same as them not being present.
You were told your thyroid is normal.
But normal on a standard TSH panel and normal in the context of early pregnancy maintenance are different thresholds. Thyroid peroxidase antibody positivity increases miscarriage risk even when TSH is within the standard reference range. The functional target for TSH at Fab Fertile is 0.5 to 2.0 mIU/mL tighter than the conventional range because subclinical dysfunction that falls within standard limits can still be contributing to the pattern. If antibodies were never tested, the thyroid picture is incomplete.
You were told progesterone was low and given a supplement.
But supplementing progesterone without investigating why it is low addresses the symptom, not the source. Low progesterone can reflect adrenal insufficiency, thyroid dysfunction, nutrient depletion, or poor corpus luteum function downstream of egg quality. If those drivers are still present in the next pregnancy, the same hormonal environment is still present.
You were told the clotting panel was negative.
But the standard thrombophilia panel does not include homocysteine, does not assess methylation status, and does not account for the broader inflammatory burden that compounds clotting risk. A negative antiphospholipid panel does not mean clotting is not part of the pattern. It means the specific markers on that panel were not elevated.
You were told your partner's semen analysis was normal.
But a normal semen analysis does not assess sperm DNA fragmentation. In recurrent pregnancy loss, where the embryo is implanting but not surviving, the integrity of the paternal DNA contribution to early embryo development is directly relevant. It is not tested in a standard workup. That means it has never been ruled out.
You were told diet and lifestyle changes should help.
But generalized recommendations are not the same as a personalized protocol built on what your specific testing shows. We have worked with couples who had already changed everything diet, supplements, sleep, stress and were still losing pregnancies. Not because the changes were wrong. Because they were not targeted to the actual pattern driving the losses. You cannot optimize a system you have not measured.
For a deeper look at what the functional approach to miscarriage investigation covers, listen to our episode on why addressing common miscarriage themes can help improve pregnancy success and our episode on causes of miscarriage before 12 weeks -- what most doctors miss.
A Functional Fertility Audit: Recurrent Pregnancy Loss
This is how we read the picture at Fab Fertile, compared to what a standard RPL workup typically covers. The italicized notes describe what the pattern often looks like clinically.
|
Area |
Conventional View |
Fab Fertile Pattern Interpretation |
|---|---|---|
|
Miscarriage Workup Timing |
Investigation typically begins after two to three losses. Standard panel covers uterine anatomy, parental karyotyping, and antiphospholipid antibody syndrome. A cause is identified in fewer than half of cases. |
Full functional evaluation after the first loss if the clinical picture warrants it, and after two losses without exception. We do not wait for a third loss to start asking the right questions. The pattern we see most often: couples who spent two or three years in the wait-and-see cycle while the underlying drivers immune activation, gut dysbiosis, methylation dysfunction remained fully intact and fully unaddressed. |
|
Immune Activation NK Cells and ANA |
NK cell testing not routinely recommended and considered controversial. ANA not ordered unless there is an existing autoimmune diagnosis. Antiphospholipid panel covers lupus anticoagulant and anticardiolipin antibodies only. |
Natural killer cell activity, ANA, and broader immune markers evaluated where the clinical history points to immune involvement. Thyroid peroxidase antibodies checked as part of the immune picture regardless of TSH result. The pattern: recurrent unexplained loss, normal uterine anatomy, normal standard clotting panel, and a personal or family history of autoimmune conditions. Thyroid antibodies elevated but TSH technically normal. ANA positive but below diagnostic threshold. Each marker individually dismissed. Collectively, a clear immune picture that was never assembled. |
|
Clotting and Inflammatory Burden |
Standard thrombophilia panel covers factor V Leiden, prothrombin gene mutation, protein C and S deficiencies, and antiphospholipid antibodies. Homocysteine and hsCRP not routinely measured. |
Homocysteine, hsCRP, and methylation status evaluated alongside standard clotting markers. Functional target for homocysteine is 6.0 to 7.2 micromoles per litre. Functional target for hsCRP is below 1 mg/L. MTHFR variants assessed in the context of B12, folate, and methylation support. A pattern we consistently see: homocysteine elevated, B12 low or falsely normal due to absorption issues, folate as folic acid rather than methylfolate in the prenatal, MTHFR variants present and never connected to the loss pattern. None of it on the standard panel. All of it addressable. |
|
Thyroid, Adrenal, and Hormonal Environment |
TSH tested if symptoms are present. Progesterone supplementation offered after loss or in early pregnancy, typically synthetic. Adrenal function not assessed as part of RPL workup. |
Full thyroid panel including Free T3, Free T4, Reverse T3, and thyroid peroxidase antibodies. Functional TSH target 0.5 to 2.0 mIU/mL. Cortisol rhythm evaluated through the Dried Urine Test for Comprehensive Hormones (DUTCH), not a single blood draw. Progesterone investigated for root cause adrenal, thyroid, nutrient not just supplemented. The pattern: progesterone low, synthetic supplement prescribed, next pregnancy starts with the same adrenal and thyroid picture underneath. The supplement supported the symptom. The driver was never addressed. |
|
Gut Dysbiosis, Vaginal Microbiome, and Food Sensitivities |
Gut health not considered part of RPL evaluation. Vaginal microbiome testing limited to bacterial vaginosis or candida. Food sensitivities not assessed. |
Comprehensive stool testing using GI-MAP to identify infections, dysbiosis, and inflammatory markers. Vaginal microbiome testing to assess Lactobacillus crispatus dominance. Food sensitivity testing and elimination diet to identify immune triggers driving systemic inflammation. The clue in the history is often persistent digestive complaints, skin conditions, nutrient deficiencies that do not respond to supplementation, or a history of antibiotic use without microbiome support. When the gut is dysbiotic, every other intervention works less efficiently. When food sensitivities are present and unaddressed, the immune system is in a state of chronic activation going into every pregnancy. |
|
Paternal Contribution Sperm DNA Fragmentation |
Standard semen analysis covers count, motility, and morphology. DNA integrity not assessed unless semen analysis is abnormal. Male factor considered resolved when standard parameters are normal. |
Sperm DNA fragmentation testing as a non-negotiable part of RPL investigation. Oxidative stress, gut infections, inflammatory load, and environmental toxin exposure evaluated in the male partner using the same functional lens applied to the female. We consistently see cases where recurrent loss is attributed entirely to the female partner, but sperm DNA fragmentation has never been tested. A normal semen analysis is not a clean bill of health for DNA integrity. When the embryo is implanting but not surviving, the paternal contribution to early embryo stability cannot be assumed normal without testing it. |
The 90-Day Preparation Window
Every egg you ovulate today began developing approximately 90 days ago. Every sperm in the current cycle took approximately 74 days to mature. The biological environment both partners were in during that window the inflammatory load, the nutrient availability, the hormonal signals, the gut health, the stress response shaped what is available for the next conception attempt.
This is not a minor detail. It is the entire basis for why preparation matters before the next pregnancy, not just during it.
When couples experience recurrent pregnancy loss and move immediately into the next cycle without changing the biological environment, they are working with the same inputs. The same immune activation. The same homocysteine level. The same gut dysbiosis. The same sperm DNA fragmentation. The same cortisol pattern. The same nutrient deficiencies. Nothing has changed because nothing has been evaluated.
The 90-day window is the period when functional interventions have the greatest impact. Addressing gut infections, removing reactive foods, supporting methylation, correcting nutrient deficiencies, reducing inflammatory burden, and stabilizing the hormonal environment all of these require time to shift the biological picture in a meaningful way. A supplement started the week before an embryo transfer or a natural conception attempt is not working in the same window as one that has been in place for three months.
This is also the window that matters for sperm. Sperm DNA fragmentation driven by oxidative stress, gut infections, or inflammatory load responds to intervention but only when that intervention is in place long enough to affect the full maturation cycle. Addressing the male partner's biology two weeks before trying again is not the same as addressing it 74 days out.
The 90-day preparation window is not about delaying. It is about not repeating. Every cycle that proceeds without changing the underlying environment is a cycle with the same odds as the last one. The preparation window is where those odds actually shift.
For more on how the preparation window applies to egg development specifically, see our article on Egg Quality and Ovarian Signaling. For the connection between the preparation window and IVF outcomes in recurrent loss, see our article on Repeated IVF Failure: Patterns That Persist When Protocols Change. And for practical strategies to use this window effectively, our episode on how to improve the chances of pregnancy success after miscarriage covers the full approach.
If you have already read It Starts With the Egg and implemented the recommendations but are still experiencing loss, our episode on what to do next after reading It Starts With the Egg addresses exactly where to go from the generalized approach to the personalized one.
Pregnancy After Recurrent Loss: Cases From the Fab Fertile Community
These are not outliers. They are what becomes possible when the full biological picture is evaluated and addressed not just the loss itself.
-
Gayathri and Josh: Multiple early miscarriages, two years TTC, diet already changed, nothing holding. Seven systems addressed through the Fab Fertile Method. Pregnant naturally five months in. Watch their story
-
Pregnant Naturally at 43 With Low AMH, High FSH, and Recurrent Miscarriage
-
Pregnancy Success After Three Failed IVFs, Miscarriages, and DOR
-
Functional Fertility Testing, Late Pregnancy Loss, and Low AMH
What the Research Shows
The research on recurrent pregnancy loss is often cited in two directions either to close doors by attributing losses to chromosomal chance, or to open them selectively by focusing on a single treatable factor. The more useful lens is to look at what the evidence tells us about the systems behind the pattern.
Immune activation and NK cells.
A 2023 systematic review published in the Journal of Reproductive Immunology documented that elevated peripheral NK cell cytotoxicity is significantly associated with recurrent pregnancy loss and implantation failure, with uterine NK cell concentration emerging as an independent predictor of pregnancy outcome in women with unexplained RPL. The review noted that NK cell testing remains underutilized in clinical practice despite the consistency of the association across multiple study populations.
Tuckerman E et al. Natural killer cells and recurrent pregnancy loss. J Reprod Immunol. 2023.
Thyroid autoimmunity and miscarriage risk.
A 2025 meta-analysis confirmed that thyroid peroxidase antibody positivity is independently associated with increased miscarriage risk in both natural and assisted conception cycles, even when TSH is within the standard normal range. Thyroid antibodies have been detected in follicular fluid, suggesting direct ovarian and early embryo impact beyond the systemic hormonal effect.
Homocysteine and pregnancy loss.
A 2022 study in Frontiers in Reproductive Health found that elevated homocysteine was significantly associated with poor embryo quality and recurrent pregnancy loss, and that the association was strongest in women with diminished ovarian reserve suggesting that methylation dysfunction compounds reserve-related losses rather than operating as a separate issue.
Vaginal microbiome and early pregnancy loss.
A 2024 review in Frontiers in Cellular and Infection Microbiology confirmed that Lactobacillus crispatus dominance in the vaginal microbiome is associated with successful implantation and reduced miscarriage risk, while dysbiotic vaginal flora particularly anaerobic bacterial overgrowth is associated with implantation failure and early pregnancy loss. The review documented bidirectional communication between gut and vaginal microbiome, with gut dysbiosis amplifying vaginal dysbiosis through shared immune and hormonal pathways.
Sperm DNA fragmentation and recurrent loss.
A 2019 meta-analysis in Human Reproduction Update found that high sperm DNA fragmentation is significantly associated with recurrent pregnancy loss, with an odds ratio of 2.16 compared to fertile controls. The association held across studies using different DNA fragmentation assays and different RPL definitions, and was independent of standard semen parameters. A 2025 study of 870 ICSI cycles further documented that each 1 percent increase in DNA fragmentation reduced top-quality Day 5 blastocyst odds by 2.5 percent.
Robinson L et al. The effect of sperm DNA fragmentation on miscarriage rates: a systematic review and meta-analysis. Hum Reprod Update. 2019.
Genomic testing and recurrent loss.
A 2023 review confirmed that genomic variants affecting methylation pathways, including MTHFR, are associated with elevated homocysteine and increased miscarriage risk, and that personalized supplementation based on genetic testing improves outcomes in this population. This is the basis for the genetic testing component of the Fab Fertile evaluation not to find a single causative variant, but to personalize the methylation and nutrient support protocol.
Why Genomic Testing Can Help With Recurrent Pregnancy Loss, Birth Outcomes and Preconception Health: https://fabfertile.com/blogs/podcasts/why-genomic-testing-can-help-with-recurrent-pregnancy-loss-birth-outcomes-and-preconception-health
Antinuclear antibodies and unexplained RPL.
A 2023 study in the Journal of Reproductive Immunology found that ANA positivity was significantly more prevalent in women with unexplained recurrent pregnancy loss compared to fertile controls, and that ANA-positive women with RPL showed higher rates of implantation failure in subsequent IVF cycles even after standard RPL workup was negative. The authors concluded that ANA testing should be considered as part of routine RPL investigation rather than reserved for women with known autoimmune diagnoses.
Ticconi C et al. Antinuclear antibodies positivity in women of reproductive age. J Reprod Immunol. 2023.
Environmental toxins and pregnancy loss.
Research published in the International Journal of Environmental Research and Public Health documented associations between endocrine-disrupting chemical exposure including BPA, phthalates, and pesticide residues and increased miscarriage risk, with proposed mechanisms including disruption of implantation signaling, impaired progesterone activity, and amplified inflammatory burden. For more on reducing toxic load as part of pregnancy preparation, listen to our episode on how to reduce the risk of miscarriage and enhance fertility by eliminating toxins.
Zhang Y et al. Environmental toxin exposure and diminished ovarian reserve markers. Int J Environ Res Public Health. 2022.
The Case for a Second Opinion
If you have had more than one miscarriage and the standard workup has not found a cause, the question worth asking is not whether your providers missed something deliberately. It is whether the testing that was ordered was designed to find what is actually driving the pattern.
In most of the cases we review at Fab Fertile, the answer is no. The standard RPL panel is narrow by design. It investigates what conventional reproductive medicine has established as the primary treatable causes of recurrent loss. It does not investigate the functional systems immune activation, gut dysbiosis, vaginal microbiome, methylation, cortisol rhythm, sperm DNA that show up consistently in our case reviews and consistently go unaddressed until someone asks the right questions.
A second opinion is not about disputing your diagnosis or dismissing your care team. It is about asking whether the full picture has been evaluated before you go through another pregnancy in the same biological environment.
The couples who come to us for a Functional Fertility Second Opinion are not looking for a miracle. They are looking for information they do not yet have. They want to know whether there is something specific driving their losses, whether it is addressable, and whether the next pregnancy can start from a genuinely different place.
In most cases, there is. And it is. And it can.
That is what a second opinion is for.
For more on how to advocate for yourself in the conventional system while pursuing a functional evaluation in parallel, listen to our episode on how to be your own advocate with pregnancy loss and our episode on potential reasons for miscarriage and your options.
Related Content
If recurrent pregnancy loss is part of a broader fertility picture, these articles in the Fab Fertile series address the overlapping systems in depth:
Egg Quality and Ovarian Signaling: Why Age Alone Does Not Explain Outcomes
Low AMH in Context: What the Number Signals and What It Does Not
Diminished Ovarian Reserve: Interpreting Capacity Versus Potential
High FSH and Fertility Decisions: When the Signal Is Misread
Repeated IVF Failure: Patterns That Persist When Protocols Change
Embryo Arrest at Day 3 or Day 5: What the Pattern Often Indicates
Male Factor Fertility: The Overlooked Variable in Embryo Outcomes
Unexplained Infertility: When the Data Has Not Been Interpreted
Inflammation, Immune Signaling, and Fertility Outcomes: A Pattern-Based View
Nervous System Load and Fertility Outcomes: Why Effort Sometimes Backfires
When Repeating IVF or Moving to Donor Eggs Without New Insight Leads to the Same Outcome
Sources and Research
Tuckerman E et al. Natural killer cells and recurrent pregnancy loss. J Reprod Immunol. 2023.
Ticconi C et al. Antinuclear antibodies positivity in women of reproductive age. J Reprod Immunol. 2023.
Robinson L et al. The effect of sperm DNA fragmentation on miscarriage rates: a systematic review and meta-analysis. Hum Reprod Update. 2019.
Zhang Y et al. Environmental toxin exposure and diminished ovarian reserve markers. Int J Environ Res Public Health. 2022.
Bender Atik R et al. ESHRE guideline: recurrent pregnancy loss. Hum Reprod Open. 2023.
Practice Committee of the American Society for Reproductive Medicine. Evaluation and treatment of recurrent pregnancy loss. Fertil Steril. Updated guidance 2024.
Robinson L et al. Sperm DNA fragmentation and recurrent pregnancy loss. Curr Opin Obstet Gynecol. 2022.
Tersigni C et al. Celiac disease and reproductive failure. Hum Reprod Update. 2014.
IFM. The Inflammatory Response and Reproductive Health.
Reviewed by Dr. Labib Ghulmiyyah, MD
This content has been reviewed for alignment with the Fab Fertile clinical framework. The biological patterns and systems-based interpretations discussed in this article reflect the methodology used in Functional Fertility Second Opinion case reviews.
Dr. Labib contributes physician-level perspective to the Fab Fertile clinical framework in an advisory capacity. Clients remain under the care of their own treating physicians for all medical decisions.
Connect with Dr. Labib on LinkedIn
CURRENT VERSION VERIFIED APRIL 2026
The information provided on this website is for educational and informational purposes only and is not intended as medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition. Never disregard professional medical advice or delay seeking care because of something you have read on this website.
